As of May 30, 2026, Biomarin Pharmaceutical's top three insider holders are Jean Jacques Bienaime (Chief Executive Officer, 473.79K shares), Jean Jacques Bienaime (Chief Executive Officer, 247.43K shares), Alexander Hardy (Chief Executive Officer, 214.63K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| David E I Pyott | - | 49,750 | 0 | 23 May, 2024 |
| Henry J Fuchs | President, Worldwide Rd | 185,074 | 0 | 17 Sep, 2024 |
| Jean Jacques Bienaime | Chief Executive Officer | 473,792 | 0 | 21 May, 2024 |
| Richard A Meier | - | 127,426 | 0 | 22 May, 2025 |
| Elaine J Heron | - | 97,720 | 0 | 04 Jun, 2024 |
| V Bryan Lawlis | - | 33,140 | 0 | 24 May, 2023 |
| Willard H Dere | - | 38,950 | 0 | 22 May, 2025 |
| Ian T Clark | - | 7,000 | 0 | 05 Aug, 2025 |
| Timothy P Walbert | - | 9,780 | 0 | 22 May, 2025 |
| George Eric Davis | Evp, Chief Legal Officer | 78,560 | 0 | 19 Mar, 2026 |
| Robert J. Hombach | - | 41,870 | 0 | 22 May, 2025 |
| Brian Mueller | Evp, Chief Financial Officer | 123,314 | 0 | 19 Mar, 2026 |
| Mark J Alles | - | 15,095 | 0 | 24 May, 2023 |
| Jeffrey Robert Ajer | Evp, Chief Commercial Officer | 66,767 | 0 | 06 May, 2024 |
| Athena Countouriotis | - | 13,550 | 0 | 22 May, 2025 |
| Mark J Enyedy | - | 13,550 | 0 | 22 May, 2025 |
| Dennis Slamon | - | 31,299 | 0 | 20 Mar, 2024 |
| Maykin Ho | - | 28,010 | 0 | 22 May, 2025 |
| Barbara W. Bodem | - | 13,555 | 0 | 22 May, 2025 |
| Elizabeth M Anderson | - | 34,450 | 0 | 22 May, 2025 |
| Charles Greg Guyer | Evp, Chief Technical Officer | 84,140 | 0 | 19 Mar, 2026 |
| Erin Burkhart | Gvp, Chief Accounting Officer | 14,173 | 0 | 20 May, 2025 |
| Alexander Hardy | Chief Executive Officer | 214,635 | 0 | 19 Mar, 2026 |
| Cristin Hubbard | Evp, Chief Commercial Officer | 44,790 | 0 | 18 Mar, 2026 |
| Gregory R Friberg | Evp, Chief Rd Officer | 55,099 | 0 | 18 Mar, 2026 |
| Rashmi Virendra Ramchandani | Vp, Chief Accounting Officer | 25,610 | 0 | 22 Jan, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 18 Mar, 2026 | George Eric Davis | Common Stock | D | 1,273 | $56.05 | 78,560 | D | F |
| 17 Mar, 2026 | Alexander Hardy | Common Stock | D | 4,252 | $56.05 | 214,635 | D | F |
| 17 Mar, 2026 | Alexander Hardy | Common Stock | D | 4,252 | $56.05 | 214,635 | D | F |
| 18 Mar, 2026 | George Eric Davis | Common Stock | D | 1,273 | $56.05 | 78,560 | D | F |
| 17 Mar, 2026 | Charles Greg Guyer | Common Stock | D | 1,693 | $56.05 | 84,140 | D | F |
| 17 Mar, 2026 | Charles Greg Guyer | Common Stock | D | 1,693 | $56.05 | 84,140 | D | F |
| 17 Mar, 2026 | Brian Mueller | Common Stock | D | 2,117 | $56.05 | 123,314 | D | F |
| 17 Mar, 2026 | Brian Mueller | Common Stock | D | 2,117 | $56.05 | 123,314 | D | F |
| 16 Mar, 2026 | Cristin Hubbard | Common Stock | A | 15,410 | $0.00 | 46,035 | D | A |
| 16 Mar, 2026 | Gregory R Friberg | Common Stock | A | 19,150 | $0.00 | 56,728 | D | A |
| 16 Mar, 2026 | Gregory R Friberg | Common Stock | A | 19,150 | $0.00 | 56,728 | D | A |
| 16 Mar, 2026 | Cristin Hubbard | Common Stock | A | 15,410 | $0.00 | 46,035 | D | A |
| 17 Mar, 2026 | Gregory R Friberg | Common Stock | D | 1,629 | $56.05 | 55,099 | D | F |
| 17 Mar, 2026 | Cristin Hubbard | Common Stock | D | 1,245 | $56.05 | 44,790 | D | F |
| 17 Mar, 2026 | Gregory R Friberg | Common Stock | D | 1,629 | $56.05 | 55,099 | D | F |
| 17 Mar, 2026 | Cristin Hubbard | Common Stock | D | 1,245 | $56.05 | 44,790 | D | F |
| 16 Mar, 2026 | Cristin Hubbard | Stock Option (Right to Buy Common Stock) | A | 36,680 | $0.00 | 36,680 | D | A |
| 16 Mar, 2026 | Gregory R Friberg | Stock Option (Right to Buy Common Stock) | A | 45,600 | $0.00 | 45,600 | D | A |
| 16 Mar, 2026 | Gregory R Friberg | Stock Option (Right to Buy Common Stock) | A | 45,600 | $0.00 | 45,600 | D | A |
| 16 Mar, 2026 | Cristin Hubbard | Stock Option (Right to Buy Common Stock) | A | 36,680 | $0.00 | 36,680 | D | A |